 |
|
|
| |
PAIRED - PAtIent Reported Experiences and perceiveD benefit of treatment with dolutegravir/lamivudine (DTG/3TC): A diverse sample of people with HIV-1 (PWH) reporting high treatment satisfaction, good adherence, and high quality of life
|
| |
| |
IDWeek 2024; October 16-19, 2024; Los Angeles, CA
Jihad Slim, MD1; Andrew P. Brogan, PhD2; Gavin Harper, BA3; Katie Mycock, MChem3; Abigail McMillan, MSc3; Deanna Merrill, PharmD, MBA2; Gustavo Verdier, BSc, BPharm, MBA4
1New York Medical College, Valhalla, NY, USA; 2ViiV Healthcare, Durham, NC, USA; 3Adelphi Real World, Bollington, UK; 4ViiV Healthcare, Montreal, Canada
presenting author: Andy Brogan
410 Blackwell Street Durham, NC 27701
+1.619.627.6545
andrew.p.brogan"at"viivhealthcare.com
|
| |
|
|
|
|
|
